Notice of Closed Meeting, 7724-7725 [2021-02051]
Download as PDF
<![CDATA[
7724
Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices
For Transferor and Transferee: Mr.
Matthew D. Manahan, Counsel for
Transferor and Transferee, Pierce
Atwood LLP, 254 Commercial St.,
Portland, ME 04101, phone: (207) 791–
1189, Email: mmanahan@
pierceatwood.com.
i. FERC Contact: Mrs. Anumzziatta
Purchiaroni, (202) 502–6191 or
Anumzziatta.purchiaroni@ferc.gov.
j. Deadline for filing comments,
motions to intervene, and protests:
Within 30 days from the issuance date
of this notice.
The Commission strongly encourages
electronic filing. Please file comments,
motions to intervene, and protests using
the Commission’s eFiling system at
https://www.ferc.gov/docs-filing/
efiling.asp. Commenters can submit
brief comments up to 6,000 characters,
without prior registration, using the
eComment system at https://
www.ferc.gov/docs-filing/
ecomment.asp. You must include your
name and contact information at the end
of your comments. For assistance,
please contact FERC Online Support at
FERCOnlineSupport@ferc.gov, (866)
208–3676 (toll free), or (202) 502–8659
(TTY). In lieu of electronic filing, please
send a paper copy to: Kimberly D. Bose,
Secretary, Federal Energy Regulatory
Commission, 888 First Street NE, Room
1A, Washington, DC 20426.
Submissions sent via any other carrier
must be addressed to: Kimberly D. Bose,
Secretary, Federal Energy Regulatory
Commission, 12225 Wilkins Avenue,
Rockville, Maryland 20852. The first
page of any filing should include docket
number P–2897–052, P–2931–044, P–
2932–051, P–2941–047, P–2942–054,
and P–2984–123. Comments emailed to
Commission staff are not considered
part of the Commission record.
The Commission’s Rules of Practice
and Procedure require all intervenors
filing documents with the Commission
to serve a copy of that document on
each person on the official service list
for the project. Further, if an intervenor
files comments or documents with the
Commission relating to the merits of an
issue that may affect the responsibilities
of a resource agency, it must also serve
a copy of the document on that resource
agency.
k. Description of Transfer and Lease
of Project Lands Request: The applicants
request that the Commission approve
the transfer of the following projects
from Sappi North America, Inc. (Sappi
or Transferor) to Presumpscot Hydro
LLC (Presumpscot or Transferee):
Saccarappa Project No. 2897, Gambo
Project No. 2931, Mallison Falls Project
No. 2932, Little Falls Project No. 2941,
Dundee Project No. 2942, and Eel Weir
VerDate Sep<11>2014
16:57 Jan 29, 2021
Jkt 253001
Project No. 2984–123. The applicants
propose the transfer because of an
internal corporate reorganization that
resulted in the formation of the Sappi
subsidiary, Presumpscot. As part of the
proposed transfers, the Transferor
would retain ownership of the
transmission line properties between
the Dundee Project and Transferor’s
Westbrook Mill. In addition, the
Transferor would retain ownership of
the transmission line properties
between the Mallison Falls Project and
Transferors’ Westbrook Mill (which
transmission line connects the Gambo,
Little Falls, and Mallison Falls projects
to the mill). The applicants request
Commission approval to lease the
transmission line property to the
Transferee. Furthermore, the Transferor
requests approval to lease to the
Transferee certain lands associated with
the Saccarappa Project, including
property associated with required fish
passage facilities. By an Order issued on
April 4, 2019, the Commission approved
a surrender of the Saccarappa Project
license and related license amendments
for the Mallison Falls, Little Falls,
Gambo, and Dundee Projects. The
license surrender would become
effective upon removal of the
Saccarappa Dam and other project
works, installation of fish passage
facilities, and the completion of other
requirements. The completed fish
passage facilities would become part of
the Mallison Falls Project. The
applicants also request Commission
approval to convey in fee the proposed
leased lands occupied by the fish
passage facilities to the Transferee once
the surrender becomes effective.
l. Locations of the Applications: The
Commission provides all interested
persons an opportunity to view and/or
print the contents of this document via
the internet through the Commission’s
website at https://www.ferc.gov/docsfiling/elibrary.asp. Enter the docket
number excluding the last three digits in
the docket number field to access the
document. You may also register online
at https://www.ferc.gov/docs-filing/
esubscription.asp to be notified via
email of new filings and issuances
related to this or other pending projects.
Agencies may obtain copies of the
application directly from the applicants.
At this time, the Commission has
suspended access to the Commission’s
Public Reference Room due to the
proclamation declaring a National
Emergency concerning the Novel
Coronavirus Disease (COVID–19), issued
by the President on March 13, 2020. For
assistance, contact FERC at
FERCOnlineSupport@ferc.gov or call
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
toll free, (866) 208–3676 or TTY, (202)
502–8659.
m. Individuals desiring to be included
on the Commission’s mailing list should
so indicate by writing to the Secretary
of the Commission.
n. Comments, Protests, or Motions to
Intervene: Anyone may submit
comments, a protest, or a motion to
intervene in accordance with the
requirements of Rules of Practice and
Procedure, 18 CFR 385.210, .211, .214,
respectively. In determining the
appropriate action to take, the
Commission will consider all protests or
other comments filed, but only those
who file a motion to intervene in
accordance with the Commission’s
Rules may become a party to the
proceeding. Any comments, protests, or
motions to intervene must be received
on or before the specified comment date
for the application.
o. Filing and Service of Documents:
Any filing must (1) bear in all capital
letters the title ‘‘COMMENTS’’,
‘‘PROTEST’’, or ‘‘MOTION TO
INTERVENE’’ as applicable; (2) set forth
in the heading the name of the applicant
and the project number of the
application to which the filing
responds; (3) furnish the name, address,
and telephone number of the person
commenting, protesting or intervening;
and (4) otherwise comply with the
requirements of 18 CFR 385.2001
through 385.2005. All comments,
motions to intervene, or protests must
set forth their evidentiary basis. Any
filing made by an intervenor must be
accompanied by proof of service on all
persons listed in the service list
prepared by the Commission in this
proceeding, in accordance with 18 CFR
385.2010.
Dated: January 26, 2021.
Kimberly D. Bose,
Secretary.
[FR Doc. 2021–02059 Filed 1–29–21; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
E:\FR\FM\01FEN1.SGM
01FEN1
Federal Register / Vol. 86, No. 19 / Monday, February 1, 2021 / Notices
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE21–004: Research Grants for
Preventing Violence and Violence
Related Injury.
Date: May 25–26, 2021.
Time: 8:30 a.m.–5:00 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
CE21–005, The CDC National Centers of
Excellence in Youth Violence
Prevention (YVPCs): Rigorous
Evaluation of Prevention Strategies to
Prevent and Reduce Community Rates
of Youth Violence.
Date: June 22–24, 2021.
Time: 8:30 a.m.–5:00 p.m., EDT.
Place: Web Conference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
[FR Doc. 2021–02051 Filed 1–29–21; 8:45 am]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2021–02054 Filed 1–29–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
VerDate Sep<11>2014
16:57 Jan 29, 2021
Jkt 253001
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 86 FR 6336–6340, dated
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
7725
January 20, 2021) is amended to reflect
the Order of Succession for the Centers
for Disease Control and Prevention.
Section C–C, Order of Succession, is
hereby amended as follows:
Delete in its entirety Section C–C,
Order of Succession, and insert the
following:
During the absence or disability of the
Director, Centers for Disease Control
and Prevention (CDC), or in the event of
a vacancy in that office, the first official
listed below who is available shall act
as Director, except that during a
planned period of absence, the Director
may specify a different order of
succession:
1. Principal Deputy Director
2. Chief Medical Officer
3. Deputy Director for Public Health
Service and Implementation
Science
4. Deputy Director for Infectious
Diseases
5. Deputy Director for Public Health
Science and Surveillance
6. Deputy Director for Non-Infectious
Diseases
7. Director, National Institute for
Occupational Safety and Health
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2021–02093 Filed 1–29–21; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 86, Number 19 (Monday, February 1, 2021)]
[Notices]
[Pages 7724-7725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02051]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of
[[Page 7725]]
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--CE21-004: Research Grants for
Preventing Violence and Violence Related Injury.
Date: May 25-26, 2021.
Time: 8:30 a.m.-5:00 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Mikel Walters, Ph.D., Scientific
Review Officer, National Center for Injury Prevention and Control, CDC,
4770 Buford Highway NE, Mailstop F-63, Atlanta, Georgia 30341,
Telephone (404) 639-0913, [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-02051 Filed 1-29-21; 8:45 am]
BILLING CODE 4163-18-P
